Noxopharm (ASX:NOX) publishes preliminary data from phase one Veyonda trial
Biotech company Noxopharm (NOX) has published preliminary data from its IONIC investigator-initiated…
Noxopharm Limited (ASX:NOX)
About Noxopharm Limited
Key Information
NOX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 04/04/2024 | Tour de Cure Grant for Brain Cancer Research | 217.52KB | 265 |
| 27/02/2024 | Price Sensitive PS Appendix 4D and Half Year 2024 Financial Report | 630.13KB | 9.8K |
| 13/02/2024 | Noxopharm extends Hudson Institute strategic partnership | 219.18KB | 1.7K |
| 22/01/2024 | Price Sensitive PS December 2023 Quarterly Activities Report and Appendix 4C | 453.72KB | 1.2K |
| 18/12/2023 | Change of Director's Interest Notice - GM | 4.51KB | 391 |
| 18/12/2023 | Notification of cessation of securities - NOX | 21.54KB | 266 |
| 16/11/2023 | Results of Meeting | 277.94KB | 1.1K |
| 16/11/2023 | Price Sensitive PS Noxopharm Enhances Cash Position via R&D Rebate | 199.04KB | 384 |